NEW LEG AND FOOT ULCER TREATMENT GROUP: Healing Chronic Wounds and Saving Limbs

Any wound that doesn't show improvement in four weeks or is not healed within eight weeks is considered a non-healing or chronic wound. Our newly established Leg and Foot Ulcer Treatment Group—directed by Dr. Paul S. van Bemmelen, assistant professor of surgery, and Dr. Richard A. Clark, professor and chairman of dermatology—provides coordinated multidisciplinary care for patients with chronic ulcers (sores) on the leg, ankle, or foot.

Among the causes of such wounds are diabetes, poor circulation, bad veins, and advanced age. Fortunately, limb salvage and prevention of disfigurement and disability are achievable in the vast majority of patients.

The goal of the Leg and Foot Ulcer Treatment Group is to promote faster wound healing and decrease recurrences, with a minimum of patient visits and cost. At the initial visit, patients are evaluated by our team of specialists in vascular surgery, dermatology, podiatry, and orthotics. If indicated, plastic or orthopedic consultation is obtained.

The Leg and Foot Ulcer Treatment Group provides a complete spectrum of treatment, ranging from Unna-boots to recombinant DNA growth factor and cultured skin substitute. We have a special interest in the nonsurgical treatment of patients with poor circulation, using impulse compression technology.

Clinical research into the effectiveness of various topical treatment modalities is conducted on an ongoing basis. This allows our patients access to state-of-the-art treatment for chronic wounds. In addition, the Leg and Foot Ulcer Treatment Group will direct educational programs designed to reduce the number of patients at risk for limb loss associated with chronic wounds.

For more information, please call 631-444-4545.